DIVISLAB had a strong weekly performance, returning 2.0% and outperforming its peers. The stock's volatility was relatively low at 1.97%, indicating a stable week. In comparison, its peers DRREDDY, SUNPHARMA, and CIPLA underperformed with negative returns. The stock's Sharpe Ratio of 4.00 suggests that it was a low-risk investment this week.

[Volatility: 1.97%]